Zeer CCS / intent / ccs-ccsmed

CCS

501-1000 employees·St Petersburg, Florida, United States·ccsmed.com

Observed, not inferred · updated weekly

Buying intent

26 tracked signals | Top 15 topics are below | Sales is carrying most of it.

16signals · 30 days
25topics tracked
28.57%attributed to a team

Attention by team

LinkedIn activity, by team

Where CCS's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Leadership Development
High-impact system
Team Building
Patient Safety
Healthcare Cybersecurity
Information Security
Sales
Sales to Leadership Development: no signal
Sales to High-impact system: no signal
Sales to Team Building: no signal
Sales to Patient Safety: no signal
Medium50% of team Sales to Healthcare Cybersecurity: Medium, 50% of this team's signals
Medium50% of team Sales to Information Security: Medium, 50% of this team's signals
Others
High40% of team Others to Leadership Development: High, 40% of this team's signals
Medium20% of team Others to High-impact system: Medium, 20% of this team's signals
Medium20% of team Others to Team Building: Medium, 20% of this team's signals
Medium20% of team Others to Patient Safety: Medium, 20% of this team's signals
Others to Healthcare Cybersecurity: no signal
Others to Information Security: no signal
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Leadership Development
LinkedIn
High volume
98%
last
10d ago
High-impact system
LinkedIn
Medium volume
98%
last
19d ago
Team Building
LinkedIn
Medium volume
98%
last
10d ago
Patient Safety
LinkedIn
Medium volume
98%
last
10d ago
Healthcare Cybersecurity
LinkedIn
Medium volume
92%
last
20d ago
Information Security
LinkedIn
Medium volume
96%
last
20d ago
Healthcare Providers
LinkedIn
Medium volume
94%
last
17d ago
Health Information
LinkedIn
Medium volume
96%
last
20d ago
Patient Care
LinkedIn
Medium volume
96%
last
20d ago
Artificial Intelligence
LinkedIn
Medium volume
96%
last
17d ago
Patient Experiences
LinkedIn
Medium volume
98%
last
17d ago
Agentic AI System
LinkedIn
Medium volume
98%
last
17d ago
Workload Management
LinkedIn
Medium volume
98%
last
10d ago
Flexibility
LinkedIn
Medium volume
92%
last
28d ago
Human-Centered Design
LinkedIn
Medium volume
98%
last
25d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at CCS

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others4 active
Executiveresearching Leadership Development
in
Leadershipresearching Artificial Intelligence
in
Sales2 active
researching Healthcare Cybersecurity
in
Senior ICresearching Diabetes Education
in

Primary products / business lines

LinkedIn company profile

CCS is a leading provider of collaborative care programs and home-delivered medical supplies for those with chronic conditions, specifically diabetes. With CCS as their partner, patients are more likely to get on therapy and stay on therapy – reducing costs and improving outcomes. Our mission is to redefine at-home patient care for people living with chronic conditions by providing not only medic

Top accounts researching CCS

names withheld on the public page

These are companies whose own people brought up CCS unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

24,131 companies · 93,859 people are researching Leadership Development

CCS's own team shows 2 signals on this topic. No one outside CCS has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • High-impact system6,390 cos · 20,106 people
  • Team Building6,006 cos · 19,016 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching CCS.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Sales — 2 people; Leadership — 2 people

What's been said

public posts by CCS's team

No public post naming CCS has surfaced in the past year, so this is what CCS's own team is posting about publicly — their topics, in their words.

LinkedIn

Looking forward to attending ISPOR—The Professional Society for Health Economics and Outcomes Research 2026 in Philadelphia next week. CCS will be sharing findings from our randomized study evaluating how structured coaching and education at the time of CGM initiation impacts glycemic and patient-reported outcomes. One of the recurring themes in diabetes care is that CGM access alone is not enough. How individuals are supported in the first weeks and months after therapy initiation matters. If you’ll be at ISPOR, I’d love to connect and invite you to stop by our poster. Jason Allaire

May 2026
LinkedInMedical Supplies

CMS is continuing to modernize the prior authorization process for DMEPOS suppliers — and that could be a big win for both patients and providers. 👏 Recent CMS updates are designed to streamline prior authorizations, reduce administrative burden, and reward suppliers with strong compliance records through a potential “gold carding” exemption process. Suppliers with high provisional affirmation rates may eventually qualify for fewer prior authorization requirements. Here are important dates to take note of: June 1, 2026 — First annual “gold carding” exemption cycle officially begins for qualifying DME suppliers. January 1, 2027 — CMS electronic prior authorization API requirements go live for impacted payers. This is the major interoperability milestone many providers and suppliers are preparing for now. October 1, 2027 — Proposed compliance date for expanded electronic prior authorization rules, including drug-related prior authorization workflows and new decision timelines. This is where experienced DME partners can truly make a difference. Companies like CCS Medical have built entire teams around navigating insurance requirements, documentation workflows, and patient support for diabetes care. As CMS continues evolving these programs, suppliers that invest in compliance, education, and proactive communication will be positioned to better serve both providers and patients. The healthcare industry talks a lot about “patient-centered care” — but simplifying access to medically necessary supplies is one of the most impactful ways to deliver it. The future of DME isn’t just about shipping supplies. It’s about: 📈 Operational excellence 🤝 Provider collaboration 📚 Patient education ⚡ Speed to therapy And ultimately, helping people manage chronic conditions with fewer barriers. Excited to see CMS taking steps toward a smarter and more efficient authorization process for the DME industry. #DME #DiabetesCare #CGM #Medicare #PriorAuthorization #HealthcareInnovation #CCSMedical #ChronicCare #MedicalSupplies #HealthcareLeadership

May 2026
LinkedIn

Cardiovascular disease remains one of the leading causes of complications and death for people living with diabetes. Appreciate the American Heart Association continuing to elevate the importance of cardiometabolic care through initiatives like Outpace CVD. #LivingConnected was designed to support cardiometabolic health through blood pressure support, weight management, lifestyle coaching, medication adherence, and ongoing education alongside CGM therapy. I especially appreciate the focus on helping organizations evaluate their current approach to diabetes care and identify potential gaps in support, education, and follow-up over time. #DiabetesCare #CardiovascularDisease #ASCVD #PopulationHealth

May 2026

About this data. CCS (ccsmed.com). Department attribution is 28.57%; remaining activity is grouped under Others. Updated 2026-10-03T14:00:03.490Z.

Not yet computedPer-team narrative summaries